PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BLUE vs. GME
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


BLUEGME
YTD Return-73.72%56.13%
1Y Return-88.98%106.25%
3Y Return (Ann)-68.53%-19.45%
5Y Return (Ann)-62.56%79.72%
10Y Return (Ann)-34.78%12.91%
Sharpe Ratio-0.780.74
Sortino Ratio-1.592.32
Omega Ratio0.791.34
Calmar Ratio-0.891.27
Martin Ratio-1.162.75
Ulcer Index76.73%40.79%
Daily Std Dev113.76%152.06%
Max Drawdown-99.76%-93.43%
Current Drawdown-99.76%-68.50%

Fundamentals


BLUEGME
Market Cap$75.74M$11.98B
EPS-$2.30$0.14
PEG Ratio0.320.86
Total Revenue (TTM)$42.51M$3.47B
Gross Profit (TTM)-$21.93M$912.50M
EBITDA (TTM)-$59.39M$30.70M

Correlation

-0.50.00.51.00.2

The correlation between BLUE and GME is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

BLUE vs. GME - Performance Comparison

In the year-to-date period, BLUE achieves a -73.72% return, which is significantly lower than GME's 56.13% return. Over the past 10 years, BLUE has underperformed GME with an annualized return of -34.78%, while GME has yielded a comparatively higher 12.91% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%JuneJulyAugustSeptemberOctoberNovember
-65.51%
-1.08%
BLUE
GME

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BLUE vs. GME - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for bluebird bio, Inc. (BLUE) and GameStop Corp. (GME). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BLUE
Sharpe ratio
The chart of Sharpe ratio for BLUE, currently valued at -0.78, compared to the broader market-4.00-2.000.002.004.00-0.78
Sortino ratio
The chart of Sortino ratio for BLUE, currently valued at -1.59, compared to the broader market-4.00-2.000.002.004.006.00-1.59
Omega ratio
The chart of Omega ratio for BLUE, currently valued at 0.79, compared to the broader market0.501.001.502.000.79
Calmar ratio
The chart of Calmar ratio for BLUE, currently valued at -0.89, compared to the broader market0.002.004.006.00-0.89
Martin ratio
The chart of Martin ratio for BLUE, currently valued at -1.16, compared to the broader market0.0010.0020.0030.00-1.16
GME
Sharpe ratio
The chart of Sharpe ratio for GME, currently valued at 0.74, compared to the broader market-4.00-2.000.002.004.000.74
Sortino ratio
The chart of Sortino ratio for GME, currently valued at 2.32, compared to the broader market-4.00-2.000.002.004.006.002.32
Omega ratio
The chart of Omega ratio for GME, currently valued at 1.34, compared to the broader market0.501.001.502.001.34
Calmar ratio
The chart of Calmar ratio for GME, currently valued at 1.27, compared to the broader market0.002.004.006.001.27
Martin ratio
The chart of Martin ratio for GME, currently valued at 2.75, compared to the broader market0.0010.0020.0030.002.75

BLUE vs. GME - Sharpe Ratio Comparison

The current BLUE Sharpe Ratio is -0.78, which is lower than the GME Sharpe Ratio of 0.74. The chart below compares the historical Sharpe Ratios of BLUE and GME, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.50JuneJulyAugustSeptemberOctoberNovember
-0.78
0.74
BLUE
GME

Dividends

BLUE vs. GME - Dividend Comparison

Neither BLUE nor GME has paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
BLUE
bluebird bio, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
GME
GameStop Corp.
0.00%0.00%0.00%0.00%0.00%6.25%12.04%8.47%5.86%5.14%3.91%2.23%

Drawdowns

BLUE vs. GME - Drawdown Comparison

The maximum BLUE drawdown since its inception was -99.76%, which is greater than GME's maximum drawdown of -93.43%. Use the drawdown chart below to compare losses from any high point for BLUE and GME. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%JuneJulyAugustSeptemberOctoberNovember
-99.76%
-68.50%
BLUE
GME

Volatility

BLUE vs. GME - Volatility Comparison

bluebird bio, Inc. (BLUE) has a higher volatility of 18.20% compared to GameStop Corp. (GME) at 16.64%. This indicates that BLUE's price experiences larger fluctuations and is considered to be riskier than GME based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%JuneJulyAugustSeptemberOctoberNovember
18.20%
16.64%
BLUE
GME

Financials

BLUE vs. GME - Financials Comparison

This section allows you to compare key financial metrics between bluebird bio, Inc. and GameStop Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items